Kala BioKALA
13F holders, Q4 2024 (December 31)32holders +6
6new positions
2sold out
1famous investor
$6.94avg. 13F price*
At the end of Q4 2024, 32 institutions reported holding Kala Bio Inc. (KALA) in their 13F filings, up 6 from Q3 2024. 6 opened new positions and 2 sold out. The largest holders were Baker Bros. Advisors LP ($8.3M), Cormorant Asset Management, LP ($4.2M) and SR One Capital Management, LP ($4.2M). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Kala Bio Inc.
- CUSIP
- 483119202
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $6.6M |
| Exits | 2 | $123K |
All 13F filers, Q3 2024 → Q4 2024: 1,456,978 shares bought and 114,055 shares sold, net +1,342,923 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Baker Bros. Advisors LP | 0.09% | Add +34.8% | 1,201,894 | $8.3M |
| Cormorant Asset Management, LP | 0.23% | New | 603,027 | $4.2M |
| SR One Capital Management, LP | 1.01% | Add +35.0% | 598,940 | $4.2M |
| Silverarc Capital Management, LLC | 0.36% | New | 231,070 | $1.6M |
| ADAR1 Capital Management, LLC | 0.33% | Reduce -28.0% | 220,373 | $1.5M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.03% | Add +10.0% | 178,934 | $1.2M |
| Millennium Management | 0.00% | Reduce -3.3% | 136,056 | $944K |
| AIGH Capital Management LLC | 0.32% | New | 121,302 | $842K |
| Vanguard Group Inc. | 0.00% | No change | 53,570 | $372K |
| Geode Capital Management, LLC | 0.00% | Add +28.4% | 47,642 | $331K |
| BlackRock, Inc. | 0.00% | No change | 21,356 | $148K |
| Board of Trustees of The Leland Stanford Junior University | 0.01% | No change | 21,127 | $147K |
| Two Sigma Investments, LP | 0.00% | Reduce -15.2% | 11,877 | $82K |
| Citigroup Inc. | 0.00% | Add +1817.6% | 5,676 | $39K |
| UBS Group AG | 0.00% | Add +9179.4% | 3,155 | $22K |
| Covestor Ltd | 0.00% | No change | 969 | $7K |
| Morgan Stanley | 0.00% | Reduce -2.3% | 972 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -5.6% | 712 | $5K |
| Compagnie Lombard Odier SCmA | 0.00% | No change | 400 | $3K |
| MAI Capital Management | 0.00% | New | 300 | $2K |
| Cwm, LLC | 0.00% | No change | 200 | $1K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 120 | $833 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $694 |
| BNP Paribas Financial Markets | 0.00% | New | 98 | $680 |
| JPMorgan Chase & Co. | 0.00% | Add +50.0% | 60 | $416 |
| Bank of America Corp. | 0.00% | Add +12.1% | 37 | $257 |
| Group One Trading LLC | 0.00% | Add +633.3% | 22 | $153 |
| Curio Wealth, LLC | 0.00% | — | 20 | $139 |
| Legacy Investment Solutions, LLC | 0.00% | No change | 10 | $111 |
| Legacy Wealth Managment, LLC | 0.00% | No change | 10 | $111 |
| SBI Securities Co., Ltd. | 0.00% | — | 8 | $56 |
| Royal Bank of Canada | 0.00% | New | 2 | $0 |
"% of holder's portfolio" is KALA's weight in each manager's 13F, not the share of Kala Bio Inc. the manager owns.